Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SCY1 like pseudokinase 3 (SCYL3), also known as PACE-1, is a human protein encoded by the SCYL3 gene located on chromosome 1[1][5][7]. It contains a kinase-like domain (putative or pseudokinase, with associated but not intrinsic kinase activity)[2][3]. SCYL3 binds to the C-terminal domain of ezrin, a member of the ERM (ezrin, radixin, moesin) protein family involved in linking membrane proteins to the actin cytoskeleton[2][8]. SCYL3 localizes to both the Golgi apparatus and the cell periphery (lamellipodia), where it colocalizes with ezrin and may help regulate cell adhesion and migration—key processes for cellular motility[1][2][8]. Although implicated in cell movement and possibly in cancer biology, there is currently no evidence that SCYL3 is a direct therapeutic target, biomarker, or target of approved drugs[1][2][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SCY1 like pseudokinase 3 (SCYL3).